{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:14:59Z","timestamp":1793859299169,"version":"4.6.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/cmr.0b013e32832b2717","type":"journal-article","created":{"date-parts":[[2009,9,8]],"date-time":"2009-09-08T03:17:01Z","timestamp":1252379821000},"page":"309-315","source":"Crossref","is-referenced-by-count":11,"title":["Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma"],"prefix":"10.1097","volume":"19","author":[{"given":"John W.C.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Juan","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Keng","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ray","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuen-Kuei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley P.L.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Mo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","first-page":"1329","article-title":"Induction of Th1 response by dendritic cells pulsed with autologous melanoma apoptotic bodies","volume":"20","author":"Chang","year":"2000","journal-title":"Anticancer Res"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1084\/jem.186.7.1177","article-title":"One marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors","volume":"186","author":"Ashley","year":"1997","journal-title":"J Exp Med"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm0597-558","article-title":"Induction of antitumor activity by immunization with fusions of dendritic cells and carcinoma cells","volume":"3","author":"Gong","year":"1997","journal-title":"Nat Med"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00002371-199308000-00003","article-title":"Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution","volume":"14","author":"Storkus","year":"1993","journal-title":"J Immunother"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.183.1.283","article-title":"Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity","volume":"183","author":"Celluzzi","year":"1996","journal-title":"J Exp Med"},{"key":"R6-5-20210129","first-page":"5672","article-title":"Retroviral transduction of human dendritic cells with a tumor-associated antigen gene","volume":"56","author":"Reeves","year":"1996","journal-title":"Cancer Res"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.gt.3301880","article-title":"Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy","volume":"10","author":"Tuettenberg","year":"2003","journal-title":"Gene Ther"},{"key":"R8-5-20210129","first-page":"3329","article-title":"Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines","volume":"59","author":"Henry","year":"1999","journal-title":"Cancer Res"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.166.6.4254","article-title":"Dendritic cell injected via different routes induce immunity in cancer patients","volume":"166","author":"Fong","year":"2001","journal-title":"J Immunol"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood.V90.9.3245","article-title":"Dendritic cells: unique leukocyte populations which control the primary immune response","volume":"90","author":"Hart","year":"1997","journal-title":"Blood"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10555-007-9072-0","article-title":"Inflammatory cell infiltration of tumors: Jekyll or Hyde","volume":"26","author":"Talmadge","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat Med"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0215(20000501)86:3<385::AID-IJC13>3.0.CO;2-T","article-title":"Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells","volume":"86","author":"Mackensen","year":"2000","journal-title":"Int J Cancer"},{"key":"R15-5-20210129","first-page":"6451","article-title":"Immune and clinical responses in patients with metastatic melanoma to CD34+ progenitor-derived dendritic cell vaccine","volume":"61","author":"Banchereau","year":"2001","journal-title":"Cancer Res"},{"key":"R16-5-20210129","first-page":"3340","article-title":"Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration","volume":"59","author":"Eggert","year":"1999","journal-title":"Cancer Res"},{"key":"R17-5-20210129","first-page":"1021","article-title":"Phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer","volume":"8","author":"Chang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood-2002-07-2274","article-title":"Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen","volume":"102","author":"Gilliet","year":"2003","journal-title":"Blood"},{"key":"R19-5-20210129","first-page":"5091","article-title":"Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients","volume":"9","author":"De Vries","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R20-5-20210129","first-page":"12","article-title":"Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state","volume":"63","author":"De Vries","year":"2003","journal-title":"Cancer Res"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00262-003-0375-x","article-title":"Durable complete clinical responses in a phase I\/II trial using an autologous melanoma cell\/dendritic cell vaccine","volume":"52","author":"O'Rourke","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00008390-200412000-00016","article-title":"Malignant melanoma in Taiwan: a prognostic study of 181 cases","volume":"14","author":"Chang","year":"2004","journal-title":"Melanoma Res"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ijc.2910560524","article-title":"Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma","volume":"56","author":"Chen","year":"1994","journal-title":"Int J Cancer"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008390-199502000-00008","article-title":"Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma","volume":"5","author":"Dummer","year":"1995","journal-title":"Melanoma Res"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood.V93.5.1634","article-title":"Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells","volume":"93","author":"Steinbrink","year":"1999","journal-title":"Blood"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat Med"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.4049\/jimmunol.176.9.5637","article-title":"Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node","volume":"176","author":"Ito","year":"2006","journal-title":"J Immunol"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1245\/s10434-007-9488-3","article-title":"Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients","volume":"14","author":"McCarter","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"20884","DOI":"10.1073\/pnas.0710557105","article-title":"Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma","volume":"104","author":"Vence","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.onc.1210906","article-title":"Toll-like receptors and immune regulation: implications for cancer therapy","volume":"27","author":"Wang","year":"2008","journal-title":"Oncogene"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00008390-200910000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:01:06Z","timestamp":1786039266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008390-200910000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e32832b2717","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}